Enko®
An AI-informed crop health company, here to change how the world grows.
An AI-informed crop health company, here to change how the world grows.
Enko® is an agricultural startup that aims to revolutionize crop health with its sustainable solutions. Founded in 2017, the company has garnered attention for its innovative approach, drawing support from prominent investors such as the Bill & Melinda Gates Foundation, Anterra Capital, Finistere Ventures, Novalis LifeSciences, Germin8 Ventures, TO Ventures Food, and Rabo Food & Agri Innovation Fund. Enko® utilizes cutting-edge drug discovery techniques and applies them to agriculture, addressing issues like pest resistance and new diseases. Its disruptive model has attracted a $10.00M Series C investment as of 31 January 2023, with support from investors including Eight Roads Ventures, Akroyd LLC, Endeavor8, Nufarm, and Castor Ventures. The company's commitment to sustainability and innovation positions it as a compelling player in the Agriculture, Analytics, and Biotechnology industries, especially given its efforts to meet the evolving needs of farmers. Enko®'s disruptive approach and the support from renowned investors underline its potential impact on the agricultural sector.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series C | $10.00M | 5 |
|
31 Jan 2023 |
| Series C | $70.00M | 5 |
|
27 Jul 2022 |
| Venture Round | $2.20M | - | 11 Mar 2021 | |
| Series B | $45.00M | - | 26 Jun 2020 | |
| Venture Round | $7.50M | - | 13 Jul 2018 |
No recent news or press coverage available for Enko®.
We care about your data, and we'd love to use cookies make your experience better.
